Inovio Pharmaceuticals (INO) Competitors $3.99 +0.02 (+0.50%) (As of 09:34 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends INO vs. TCMD, RCEL, CVRX, CATX, DCTH, CERS, CLPT, OSUR, NPCE, and ANGOShould you be buying Inovio Pharmaceuticals stock or one of its competitors? The main competitors of Inovio Pharmaceuticals include Tactile Systems Technology (TCMD), AVITA Medical (RCEL), CVRx (CVRX), Perspective Therapeutics (CATX), Delcath Systems (DCTH), Cerus (CERS), ClearPoint Neuro (CLPT), OraSure Technologies (OSUR), NeuroPace (NPCE), and AngioDynamics (ANGO). These companies are all part of the "surgical & medical instruments" industry. Inovio Pharmaceuticals vs. Tactile Systems Technology AVITA Medical CVRx Perspective Therapeutics Delcath Systems Cerus ClearPoint Neuro OraSure Technologies NeuroPace AngioDynamics Inovio Pharmaceuticals (NASDAQ:INO) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, earnings, analyst recommendations, institutional ownership, profitability, valuation, media sentiment, dividends and risk. Do analysts rate INO or TCMD? Inovio Pharmaceuticals currently has a consensus target price of $38.00, suggesting a potential upside of 852.38%. Tactile Systems Technology has a consensus target price of $23.00, suggesting a potential upside of 48.48%. Given Inovio Pharmaceuticals' higher probable upside, research analysts clearly believe Inovio Pharmaceuticals is more favorable than Tactile Systems Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inovio Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Tactile Systems Technology 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67 Which has more volatility and risk, INO or TCMD? Inovio Pharmaceuticals has a beta of 0.83, suggesting that its share price is 17% less volatile than the S&P 500. Comparatively, Tactile Systems Technology has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Does the media favor INO or TCMD? In the previous week, Inovio Pharmaceuticals had 24 more articles in the media than Tactile Systems Technology. MarketBeat recorded 26 mentions for Inovio Pharmaceuticals and 2 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 0.67 beat Inovio Pharmaceuticals' score of 0.13 indicating that Tactile Systems Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inovio Pharmaceuticals 5 Very Positive mention(s) 2 Positive mention(s) 9 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Neutral Tactile Systems Technology 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is INO or TCMD more profitable? Tactile Systems Technology has a net margin of 5.42% compared to Inovio Pharmaceuticals' net margin of 0.00%. Tactile Systems Technology's return on equity of 9.24% beat Inovio Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Inovio PharmaceuticalsN/A -118.17% -83.47% Tactile Systems Technology 5.42%9.24%6.56% Do insiders and institutionals have more ownership in INO or TCMD? 26.8% of Inovio Pharmaceuticals shares are owned by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are owned by institutional investors. 2.5% of Inovio Pharmaceuticals shares are owned by insiders. Comparatively, 1.0% of Tactile Systems Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community believe in INO or TCMD? Inovio Pharmaceuticals received 349 more outperform votes than Tactile Systems Technology when rated by MarketBeat users. Likewise, 71.19% of users gave Inovio Pharmaceuticals an outperform vote while only 69.81% of users gave Tactile Systems Technology an outperform vote. CompanyUnderperformOutperformInovio PharmaceuticalsOutperform Votes71971.19% Underperform Votes29128.81% Tactile Systems TechnologyOutperform Votes37069.81% Underperform Votes16030.19% Which has better valuation & earnings, INO or TCMD? Tactile Systems Technology has higher revenue and earnings than Inovio Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInovio Pharmaceuticals$830K125.47-$135.12MN/AN/ATactile Systems Technology$274.42M1.35$28.51M$0.6523.83 SummaryTactile Systems Technology beats Inovio Pharmaceuticals on 10 of the 17 factors compared between the two stocks. Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Get Inovio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INO vs. The Competition Export to ExcelMetricInovio PharmaceuticalsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$104.14M$4.47B$5.07B$8.90BDividend YieldN/A36.79%4.99%4.07%P/E RatioN/A13.2787.8613.46Price / Sales125.4744.831,228.8287.66Price / CashN/A52.2739.5136.27Price / Book1.415.776.946.30Net Income-$135.12M$13.76M$119.12M$225.93M7 Day Performance-16.35%-1.10%-1.84%-1.32%1 Month Performance-30.49%0.56%-3.65%0.60%1 Year Performance-93.37%50.90%31.64%26.23% Inovio Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INOInovio Pharmaceuticals3.6092 of 5 stars$3.99+0.5%$38.00+852.4%-93.4%$104.14M$830,000.000.00127Analyst ForecastAnalyst RevisionTCMDTactile Systems Technology3.7846 of 5 stars$15.49-0.4%$23.00+48.5%+23.1%$371.76M$274.42M23.94980RCELAVITA Medical1.4051 of 5 stars$13.05+0.7%$16.50+26.4%+4.1%$342.17M$50.14M0.00130CVRXCVRx2.1065 of 5 stars$13.52+0.7%$15.83+17.1%-25.8%$328.00M$39.29M0.00200CATXPerspective Therapeutics2.7597 of 5 stars$4.67-24.3%$21.57+361.9%N/A$315.65M$1.43M0.00116Analyst RevisionDCTHDelcath Systems3.5248 of 5 stars$9.78+1.6%$21.50+119.8%+256.7%$312.67M$2.07M0.0076CERSCerus2.6525 of 5 stars$1.68+1.2%$3.63+115.8%-7.3%$311.99M$156.37M0.00625Positive NewsCLPTClearPoint Neuro0.7629 of 5 stars$10.96-0.1%$11.33+3.4%+88.2%$302.28M$23.95M0.00110OSUROraSure Technologies4.4944 of 5 stars$3.81-1.3%$6.67+75.0%-47.2%$284.19M$405.47M25.40638NPCENeuroPace3.7719 of 5 stars$9.22+0.3%$14.60+58.4%+5.6%$275.22M$65.42M0.00170Analyst RevisionANGOAngioDynamics4.7568 of 5 stars$6.72flat$12.00+78.6%-1.9%$273.03M$303.91M-1.11748Positive News Related Companies and Tools Related Companies Tactile Systems Technology Alternatives AVITA Medical Alternatives CVRx Alternatives Perspective Therapeutics Alternatives Delcath Systems Alternatives Cerus Alternatives ClearPoint Neuro Alternatives OraSure Technologies Alternatives NeuroPace Alternatives AngioDynamics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inovio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INO Stock Alerts